‌

US Patent 9274126 Risk factors and prediction of myocardial infarction

Patent 9274126 was granted and assigned to BG Medicine on March, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

BG Medicine

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9274126

Patent Inventor Names

Aram S. Adourian0

Yu Guo0

Xiaohong Li0

Pieter Muntendam0

Date of Patent

March 1, 2016

Patent Application Number

12946470

Date Filed

November 15, 2010

Patent Primary Examiner

‌

Yelena G. Gakh

Patent abstract

Biomarkers and methods are disclosed for diagnosing the risk of a myocardial infarction in an individual by measuring the levels of a set of biomarkers in a sample from an individual. A risk score is calculated for the individual by weighting the measured levels of the biomarkers. The risk score then is used to identify whether the individual is likely to experience a myocardial infarction. In addition, kits are disclosed that include a set of reagents for specifically measuring biomarker levels in a sample from an individual.